Literature DB >> 28839745

A candidal oesophageal stricture responsive to fluconazole therapy.

Rahul Kalla1, Vishal Kaushik2.   

Abstract

We report a case of candidal oesophageal stricture in an 81 year-old man with a 2 year history of gradual onset dysphagia and odynophagia to solids. Although rare, most cases have reported treatment success with oesophageal balloon dilation. We report the first case of candidal oesophageal stricture resolution with a prolonged course of anti-fungal therapy.

Entities:  

Keywords:  DYSPHAGIA; ENDOSCOPIC ULTRASONOGRAPHY; OESOPHAGEAL STRICTURES

Year:  2013        PMID： 28839745      PMCID： PMC5369705          DOI： 10.1136/flgastro-2013-100337

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


  8 in total

1.  Esophagomediastinal fistula and esophageal stricture as a complication of esophageal candidiasis: a case report.

Authors:  B W Kim; S H Cho; S E Rha; H Choi; K Y Choi; S B Cha; M G Choi; I S Chung; H S Sun; D H Park
Journal:  Gastrointest Endosc       Date:  2000-12       Impact factor: 9.427

2.  Candida esophagitis complicated by esophageal stricture.

Authors:  J J Hyun; H J Chun; B Keum; Y S Seo; Y S Kim; Y T Jeen; H S Lee; S H Um; C D Kim; H S Ryu
Journal:  Endoscopy       Date:  2010-07-16       Impact factor: 10.093

Review 3.  Reflux strictures of the esophagus.

Authors:  W H Kuo; A N Kalloo
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-04

4.  Eosinophilic esophagitis misdiagnosed twice as esophageal candidiasis.

Authors:  Javier Molina Infante; Lucia Ferrando Lamana
Journal:  Gastrointest Endosc       Date:  2010-02       Impact factor: 9.427

Review 5.  Surgery for peptic strictures.

Authors:  J Mamazza; C M Schlachta; E C Poulin
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-04

6.  The first description of an oesophageal candidosis by Bernhard von Langenbeck in 1839.

Authors:  M Knoke; H Bernhardt
Journal:  Mycoses       Date:  2006-07       Impact factor: 4.377

Review 7.  Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors:  K L Goa; L B Barradell
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 8.  Oesophageal candidiasis in elderly patients: risk factors, prevention and management.

Authors:  Namal Weerasuriya; Jeremy Snape
Journal:  Drugs Aging       Date:  2008       Impact factor: 4.271
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.